ArticleJournal of cancer research and clinical oncology2023
Enhanced breast mass mammography classification approach based on pre-processing and hybridization of transfer learning models.
Article in Journal of cancer research and clinical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 7 citations in OpenAlex.
- Deep Learning-Based Analysis of Mammographic Images for Breast Cancer Detection Using Transfer Learning.Healthcare technology lettersArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveThe second most prevalent cause of death among women is now breast cancer, surpassing heart disease. Mammography images must accurately identify breast masses to diagnose early breast cancer, which can significantly increase the patient's survival percentage. Although, due to the diversity of breast masses and the complexity of their microenvironment, it is still a significant issue. Hence, an issue that researchers need to continue searching into is how to establish a reliable breast mass detection approach in an effective factor application to increase patient survival. Even though several machine and deep learning-based approaches were proposed to address these issues, pre-processing strategies and network architectures were insufficient for breast mass detection in mammogram scans, which directly influences the accuracy of the proposed models.
methodsAiming to resolve these issues, we propose a two-stage classification method for breast mass mammography scans. First, we introduce a pre-processing stage divided into three sub-strategies, which include several filters for Region Of Interest (ROI) extraction, noise removal, and image enhancements. Secondly, we propose a classification stage based on transfer learning techniques for feature extraction, and global pooling for classification instead of standard machine learning algorithms or fully connected layers. However, instead of using the traditional fine-tuning feature extraction phase, we proposed a hybrid model where we concatenate two recent pre-trained CNNs to assist the feature extraction phase, rather than using one.
resultsUsing the CBIS-DDSM dataset, we managed to increase mainly each of the accuracy, sensitivity, and specificity reaching the highest accuracy of 98,1% using the Median filter for noise removal. Followed by the Gaussian filter trial with 96% accuracy, meanwhile, the winner filter attained the lowest accuracy of 94.13%. Moreover, the usage of global average pooling as a classifier is suitable in our case better than global max pooling.
conclusionThe experimental findings demonstrate that the suggested strategy of breast Mass detection in mammography can outperform the top-ranked methods currently in use in terms of classification performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.